Overview
Malignant melanoma is one of the most dangerous forms of skin cancer, originating in melanocytes—the pigment-producing cells. It accounts for a small percentage of skin cancer cases but is responsible for the majority of skin cancer-related deaths. The disease can develop anywhere on the body, including areas not exposed to the sun, such as the soles of the feet or under nails. Risk factors include excessive UV radiation exposure, fair skin, a history of sunburns, and genetic predisposition. Early-stage melanoma is often treatable, but advanced stages can metastasize to other organs, significantly reducing survival rates. Public awareness and early detection through regular skin checks are vital for improving outcomes.
Key Features
Malignant melanoma is distinguished by its rapid growth and high metastatic potential. The ABCDE rule (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolving) helps identify suspicious lesions. Biopsy and histopathological examination confirm the diagnosis. Molecular profiling has revealed mutations in genes like BRAF, NRAS, and KIT, which are targets for modern therapies. Immunotherapy and targeted treatments have revolutionized management, offering hope for advanced cases. However, resistance to therapy remains a challenge, driving ongoing research into novel treatment approaches.
Application Areas
Malignant melanoma is a focus in oncology, dermatology, and pathology. Dermatologists play a key role in early detection, while oncologists manage treatment plans, including surgery, radiation, immunotherapy, and targeted therapy. Research institutions study melanoma's molecular mechanisms to develop new drugs and biomarkers. Public health campaigns emphasize prevention through sun protection and regular skin screenings. Collaboration across disciplines is essential to improve patient outcomes and reduce mortality rates.
Precautions
Preventing melanoma starts with minimizing UV exposure. Use broad-spectrum sunscreen with SPF 30+, wear protective clothing, and avoid tanning beds. Regular self-examinations and professional skin checks can detect early signs. For diagnosed patients, adherence to follow-up schedules is crucial to monitor recurrence. Genetic counseling may be recommended for families with a history of melanoma. Patients should report any new or changing skin lesions promptly to their healthcare provider.
B2B Procurement Guide
Hospitals and clinics procuring melanoma treatments should consider factors like efficacy, cost, and patient-specific needs. Immunotherapies (e.g., checkpoint inhibitors) and targeted therapies (e.g., BRAF inhibitors) are high-cost options but can be life-saving. Suppliers should provide detailed product information, including storage requirements and administration protocols. Bulk purchasing agreements and partnerships with pharmaceutical distributors can help manage costs. Always verify the authenticity and regulatory compliance of medications to ensure patient safety.
Related Manufacturers
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、人恶性黑色素瘤瘤株、科研试剂
- 主营：大鼠白介素、小鼠脂联素、表皮生长因子、小鼠黑色素瘤、ELISA试剂盒、细胞因子、重组蛋白
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、蛋白、抗体、细胞、检测试剂盒
- 主营：ELISA试剂盒、PCR试剂盒、科研试剂
- 主营：igg抗体、糖蛋白、试剂盒、人瘦素、人蛋白、人胆酸、脂蛋白、粗纤维、猪睾酮、烯二酮、nad激酶、测试盒、牛瘦素、牛胆酸、原果胶、磷酸酶、犬肾素、含水量、甜菜碱、igm抗体、dna抗体、磷脂酶、大鼠超、犬叶酸、样受体
- 主营：科研试剂盒、酶免试剂盒、elisa试剂盒、细胞、生物试剂、进口ELISA试剂盒、PCR试剂盒、生化测试盒
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、脂蛋白、关基因、亲环素、钾通道、列抗体、ntp溶液、蛋白酶、脑蛋白、病毒抗、蛋白质、239抗体、dtt溶液、科研试剂
- 主营：检测方、钠尿肽、试剂盒、同源物、ep300检测、结合蛋白、大鼠c-肽(、微球蛋白、抗胰蛋白酶、淋巴瘤因子、蛋白磷酸酶、死亡激动剂、核心域蛋白1、大鼠e选择素、大鼠janus激酶、激活蛋白激酶、大鼠ⅱ型胶原、大鼠ⅳ型胶原、大鼠klotho蛋白、细胞激活因子、大鼠ⅲ型胶原、大鼠nadh脱氢酶1、大鼠ⅵ型胶原α1、elisa 检测试剂盒
- 主营：酶cγ链、α2巨球、素d合成、纤连蛋白、抗组蛋白、肌醇抗体、蛋白样环、敏感蛋白、牛骨钙素、蛋白重链、金属肽酶、乳球蛋白、钩端螺旋、蛋白激酶、高血糖素、钙调蛋白、小鼠α1抗、ELISA试剂盒、pcr检测试剂、生化检测试剂
- 主营：ELISA试剂盒、抗体
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、小鼠皮肤黑色素瘤细胞、科研试剂
- 主营：科研试剂盒、酶免试剂盒、elisa试剂盒、生化试剂盒、细胞、生物试剂、进口ELISA试剂盒、PCR试剂盒、生化测试盒
- 主营：黑色素瘤标记物、elisa试剂盒
- 主营：人胚肾细胞、膀胱癌细胞、前列腺癌细胞
- 主营：人检测试剂盒、检测试剂盒